Latest Cleveland Clinic Stories

Biopsies reveal nature of brain lesions early in MS progression, countering conventional wisdom Working together, researchers at Cleveland Clinic and Mayo Clinic have for the first time examined early multiple sclerosis (MS) brain lesions in the cerebral cortex. These lesions are thought to be critical to MS progression and the researchers found that the lesions are distinctly different than previously speculated, giving clues to better disease management. The long-accepted theory has...

Innovator, medical pioneer Dr. Eric Topol predicts consumer revolution in new eBook launched today WASHINGTON, Dec. 5, 2011 /PRNewswire-USNewswire/ -- The way medicine is currently practiced will be fundamentally transformed by a new consumer revolution, predicts renowned cardiologist and visionary Dr. Eric J. Topol in his new eBook released today. The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care is now available for purchase...

One-time injection allows relief from pain for 8 months A collaborative research group – led by researchers at Cleveland Clinic – published findings that indicate a one-time injection immediately after spinal cord injury can limit pain for an extended period of time. Fibronectin – a protein that exists naturally in humans – supports the survival, growth and communication of neurons in the brain and spinal cord. The researchers discovered, through testing in an animal model, that...

Researchers at Cleveland Clinic reported today that administration of a new drug– evacetrapib – can dramatically increase HDL (good) cholesterol, while significantly lowering LDL (bad) cholesterol). At the highest tested dosage, the levels of HDL more than doubled. The study was presented today by lead investigator Stephen Nicholls MD PhD, Cardiovascular Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5), at the American Heart Association's Scientific...

SAN FRANCISCO, Nov. 9, 2011 /PRNewswire/ -- Scripps Health's Eric J. Topol, MD, a world-renowned cardiologist and physician-scientist, was presented the 2011 TCT Career Achievement Award in a ceremony held today during the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The award is given each year to a pioneer in the field of interventional cardiovascular medicine by the Cardiovascular Research Foundation (CRF), sponsor of the TCT symposium. (Photo:...

CLEVELAND, Nov. 7, 2011 /PRNewswire/ -- Case Western Reserve University School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin - Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals as national leaders in teaching, research, and patient care in the field of integrative oncology. The gifts from The Parker Foundation and Helen Moss Cancer...

CLEVELAND, Nov. 1, 2011 /PRNewswire/ -- Cleveland Clinic unveiled "Harnessing BIG DATA" as one of the 2012 Top Ten medical innovations at the Clinic's annual Medical Innovation Summit in October. Explorys was formed to harness BIG DATA for medical advancement, providing a structured way to collect, store, aggregate, easily access and analyze the incomprehensible amount of data that is created on a daily basis. In the world of healthcare, dynamic data management technology plays a vital part...

Gene promotes prostate cancer when 'turned on,' breast cancer when “turned off” Researchers at Cleveland Clinic have discovered that a gene – known as an androgen receptor (AR) – is found in both prostate and breast cancers yet has opposite effects on these diseases. In prostate cancer, the AR gene promotes cancer growth when the gene is "turned on." In breast cancer, the AR gene promotes cancer growth when the gene is "turned off," as is often the case after menopause, when AR...

(Ivanhoe Newswire) – Guys, before you take that daily supplement, read this!  According to a new study, men who were randomized to receive daily supplementation with vitamin E had a significantly increased risk of prostate cancer. Lifetime risk of prostate cancer in the United States is currently estimated to be 16 percent. Although most cases are found at an early, curable stage, treatment is costly and urinary, sexual, and bowel-related adverse effects are common. The long-term...

New evidence that taking vitamin E supplements can be risky to your health adds to the concerns that doctors have that many people may be overusing vitamins and other supplements. A new study that followed up on men who took high doses of vitamin E for around five years found they had a slightly increased risk of developing prostate cancer -- even after they had stopped taking the pills. The study, published today in the Journal of the American Medical Association, followed more than...